Skip to search formSkip to main contentSkip to account menu

TAK 390MR

Known as: (+)-2-((R)-{(3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl}sulfinyl)-1H-benzimidazole, TAK-390MR, TAK390MR 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

dexlansoprazole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
M1894 An Updated Model of Intragastric pH and Erosive Esophagitis (EE) Healing Using 24-Hour Intragastric pH Values to Predict EE Healing: Validation By Data from TAK-390MR
2009
2009
M1892 The Effect of Time-of-Day Dosing of TAK-390MR On the Pharmacokinetics and Pharmacodynamics of TAK-390: Evidence for Dosing Flexibility with This Dual Delayed Release Proton Pump Inhibitor
2008
2008
S1095 The Pharmacokinetics of TAK-390mr 60 mg, a Dual Delayed Release Formulation of the Proton Pump Inhibitor TAK-390, and Lansoprazole 60 mg: A Retrospective Analysis
2008
2008
Placebo-Controlled Trial of 2 Doses of TAK-390MR, a PPI with Novel Dual Delayed Release Technology, as Maintenance Treatment for Patients with Healed Erosive Esophagitis (EE): 13
2008
2008
Long-Term Safety of TAK-390MR, a PPI with a Novel Dual Delayed Release Formulation, in GERD Patients: 14
2008
2008
TAK-390MR Maintains Relief of Gastroesophageal Reflux Disease (GERD) Symptoms and Improvements in Quality of Life in GERD Patients with Healed Erosive Esophagitis: 57
2007
2007
TAK-390MR vs. Lansoprazole (LAN) for Maintenance of Drug Concentration above a Threshold Which Corresponds to Higher%-Time pH > 4: 15
2007
2007
INFLAMMATORY BOWEL DISEASE
Purpose: On the basis of results from small studies using conventional ambulatory catheter-based esophageal pH testing, it has… 
2007
2007
COLORECTAL CANCER PREVENTION
2007
2007
The Effect and Timing of Food on the Pharmacokinetics and Pharmacodynamics of TAK-390MR (Modified Release): Evidence for Dosing Flexibility: 78
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)